Medium-sized graduated syringe (1/2 liquid)

[{"image":"https://icons.cdn.biorender.com/w75xh75/6793dcfd1d3750e8e0219ca8/6793d9fb1d3750e8e0219a3d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793dcfd1d3750e8e0219ca8/6793d9fb1d3750e8e0219a3d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793dcfd1d3750e8e0219ca9/6793d9fb1d3750e8e0219a3d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793dcfd1d3750e8e0219ca9/6793d9fb1d3750e8e0219a3d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793dcfd1d3750e8e0219caa/6793d9fb1d3750e8e0219a3d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793dcfd1d3750e8e0219caa/6793d9fb1d3750e8e0219a3d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793dcfd1d3750e8e0219cab/6793d9fb1d3750e8e0219a3d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793dcfd1d3750e8e0219cab/6793d9fb1d3750e8e0219a3d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793dcfd1d3750e8e0219cac/6793d9fb1d3750e8e0219a3d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793dcfd1d3750e8e0219cac/6793d9fb1d3750e8e0219a3d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793dcfd1d3750e8e0219cad/6793d9fb1d3750e8e0219a3d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793dcfd1d3750e8e0219cad/6793d9fb1d3750e8e0219a3d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793dcfd1d3750e8e0219cae/6793d9fb1d3750e8e0219a3d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793dcfd1d3750e8e0219cae/6793d9fb1d3750e8e0219a3d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793dcfd1d3750e8e0219caf/6793d9fb1d3750e8e0219a3d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793dcfd1d3750e8e0219caf/6793d9fb1d3750e8e0219a3d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793dcfd1d3750e8e0219cb0/6793d9fb1d3750e8e0219a3d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793dcfd1d3750e8e0219cb0/6793d9fb1d3750e8e0219a3d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793dcfd1d3750e8e0219cb1/6793d9fb1d3750e8e0219a3d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793dcfd1d3750e8e0219cb1/6793d9fb1d3750e8e0219a3d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793dcfd1d3750e8e0219cb2/6793d9fb1d3750e8e0219a3d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793dcfd1d3750e8e0219cb2/6793d9fb1d3750e8e0219a3d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793dcfd1d3750e8e0219cb3/6793d9fb1d3750e8e0219a3d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793dcfd1d3750e8e0219cb3/6793d9fb1d3750e8e0219a3d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793dcfd1d3750e8e0219cb4/6793d9fb1d3750e8e0219a3d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793dcfd1d3750e8e0219cb4/6793d9fb1d3750e8e0219a3d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793dcfd1d3750e8e0219cb5/6793d9fb1d3750e8e0219a3d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793dcfd1d3750e8e0219cb5/6793d9fb1d3750e8e0219a3d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793dcfd1d3750e8e0219cb6/6793d9fb1d3750e8e0219a3d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793dcfd1d3750e8e0219cb6/6793d9fb1d3750e8e0219a3d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793dcfd1d3750e8e0219cb7/6793d9fb1d3750e8e0219a3d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793dcfd1d3750e8e0219cb7/6793d9fb1d3750e8e0219a3d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793dcfd1d3750e8e0219cb8/6793d9fb1d3750e8e0219a3d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793dcfd1d3750e8e0219cb8/6793d9fb1d3750e8e0219a3d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793dcfd1d3750e8e0219cb9/6793d9fb1d3750e8e0219a3d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793dcfd1d3750e8e0219cb9/6793d9fb1d3750e8e0219a3d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793dcfd1d3750e8e0219cba/6793d9fb1d3750e8e0219a3d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793dcfd1d3750e8e0219cba/6793d9fb1d3750e8e0219a3d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793dcfd1d3750e8e0219cbb/6793d9fb1d3750e8e0219a3d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793dcfd1d3750e8e0219cbb/6793d9fb1d3750e8e0219a3d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793dcfd1d3750e8e0219cbc/6793d9fb1d3750e8e0219a3d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793dcfd1d3750e8e0219cbc/6793d9fb1d3750e8e0219a3d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793dcfd1d3750e8e0219cbd/6793d9fb1d3750e8e0219a3d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793dcfd1d3750e8e0219cbd/6793d9fb1d3750e8e0219a3d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793dcfd1d3750e8e0219cbe/6793d9fb1d3750e8e0219a3d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793dcfd1d3750e8e0219cbe/6793d9fb1d3750e8e0219a3d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793dcfd1d3750e8e0219cbf/6793d9fb1d3750e8e0219a3d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793dcfd1d3750e8e0219cbf/6793d9fb1d3750e8e0219a3d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793dcfd1d3750e8e0219cc0/6793d9fb1d3750e8e0219a3d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793dcfd1d3750e8e0219cc0/6793d9fb1d3750e8e0219a3d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793dcfd1d3750e8e0219cc1/6793d9fb1d3750e8e0219a3d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793dcfd1d3750e8e0219cc1/6793d9fb1d3750e8e0219a3d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793dcfd1d3750e8e0219cc2/6793d9fb1d3750e8e0219a3d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793dcfd1d3750e8e0219cc2/6793d9fb1d3750e8e0219a3d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793dcfd1d3750e8e0219cc3/6793d9fb1d3750e8e0219a3d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793dcfd1d3750e8e0219cc3/6793d9fb1d3750e8e0219a3d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793dcfd1d3750e8e0219cc4/6793d9fb1d3750e8e0219a3d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793dcfd1d3750e8e0219cc4/6793d9fb1d3750e8e0219a3d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793dcfd1d3750e8e0219cc5/6793d9fb1d3750e8e0219a3d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793dcfd1d3750e8e0219cc5/6793d9fb1d3750e8e0219a3d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793dcfd1d3750e8e0219cc6/6793d9fb1d3750e8e0219a3d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793dcfd1d3750e8e0219cc6/6793d9fb1d3750e8e0219a3d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793dcfd1d3750e8e0219cc7/6793d9fb1d3750e8e0219a3d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793dcfd1d3750e8e0219cc7/6793d9fb1d3750e8e0219a3d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793dcfd1d3750e8e0219cc8/6793d9fb1d3750e8e0219a3d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793dcfd1d3750e8e0219cc8/6793d9fb1d3750e8e0219a3d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793dcfd1d3750e8e0219cc9/6793d9fb1d3750e8e0219a3d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793dcfd1d3750e8e0219cc9/6793d9fb1d3750e8e0219a3d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793dcfd1d3750e8e0219cca/6793d9fb1d3750e8e0219a3d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793dcfd1d3750e8e0219cca/6793d9fb1d3750e8e0219a3d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793dcfd1d3750e8e0219ccb/6793d9fb1d3750e8e0219a3d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793dcfd1d3750e8e0219ccb/6793d9fb1d3750e8e0219a3d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793dcfd1d3750e8e0219ccc/6793d9fb1d3750e8e0219a3d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793dcfd1d3750e8e0219ccc/6793d9fb1d3750e8e0219a3d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793dcfd1d3750e8e0219ccd/6793d9fb1d3750e8e0219a3d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793dcfd1d3750e8e0219ccd/6793d9fb1d3750e8e0219a3d.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6793dcfd1d3750e8e0219cce/6793d9fb1d3750e8e0219a3d.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6793dcfd1d3750e8e0219cce/6793d9fb1d3750e8e0219a3d.png"}]